Literature DB >> 8152450

Second-line drug therapy for rheumatoid arthritis.

J M Cash1, J H Klippel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8152450     DOI： 10.1056/NEJM199405123301908

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  26 in total

1.  Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis.

Authors:  J van Aken; L R Lard; S le Cessie; J M W Hazes; F C Breedveld; T W J Huizinga
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

2.  Enhancement of the effect of methotrexate on collagen II induced arthritis in mice by nicotinamide.

Authors:  H Kröger; A Hauschild; M Ohde; W Thefeld; D Krüger; K Bache; W Ehrlich
Journal:  Inflammation       Date:  1998-06       Impact factor: 4.092

3.  Enhancement of the anti-inflammatory and anti-arthritic effects of theophylline by a low dose of a nitric oxide donor or non-specific nitric oxide synthase inhibitor.

Authors:  Adel Gomaa; Mohsen Elshenawy; Noha Afifi; Eman Mohammed; Romany Thabit
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

4.  The incidence of upper and lower extremity surgery for rheumatoid arthritis among Medicare beneficiaries.

Authors:  Jennifer Waljee; Lin Zhong; Onur Baser; Huseyin Yuce; David A Fox; Kevin C Chung
Journal:  J Bone Joint Surg Am       Date:  2015-03-04       Impact factor: 5.284

Review 5.  Use of biologics in rheumatoid arthritis: current and emerging paradigms of care.

Authors:  Jeffrey R Curtis; Jasvinder A Singh
Journal:  Clin Ther       Date:  2011-06       Impact factor: 3.393

Review 6.  Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.

Authors:  Jasvinder A Singh; Alomgir Hossain; Amy S Mudano; Elizabeth Tanjong Ghogomu; Maria E Suarez-Almazor; Rachelle Buchbinder; Lara J Maxwell; Peter Tugwell; George A Wells
Journal:  Cochrane Database Syst Rev       Date:  2017-05-08

7.  Involvement of simultaneous multiple transcription factor expression, including cAMP responsive element binding protein and OCT-1, for synovial cell outgrowth in patients with rheumatoid arthritis.

Authors:  S Wakisaka; N Suzuki; M Takeno; Y Takeba; H Nagafuchi; N Saito; H Hashimoto; T Tomita; T Ochi; T Sakane
Journal:  Ann Rheum Dis       Date:  1998-08       Impact factor: 19.103

Review 8.  Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach.

Authors:  F Richy; O Bruyere; O Ethgen; V Rabenda; G Bouvenot; M Audran; G Herrero-Beaumont; A Moore; R Eliakim; M Haim; J-Y Reginster
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

9.  A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China.

Authors:  Dawei Hu; Chunde Bao; Shunle Chen; Jieruo Gu; Zhanguo Li; Lingyun Sun; Xinghai Han; Liqing Ni
Journal:  Rheumatol Int       Date:  2008-08-15       Impact factor: 2.631

Review 10.  Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.

Authors:  Jasvinder A Singh; Alomgir Hossain; Elizabeth Tanjong Ghogomu; Amy S Mudano; Lara J Maxwell; Rachelle Buchbinder; Maria Angeles Lopez-Olivo; Maria E Suarez-Almazor; Peter Tugwell; George A Wells
Journal:  Cochrane Database Syst Rev       Date:  2017-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.